Want to create an interactive transcript for this episode?
Podcast: Foundation Fighting Blindness
Episode: Eye on the Cure Podcast | Episode 92: Lance Baldo, MD
Description: Lance Baldo, MD, CEO at Beacon Therapeutics, talks to host Ben Shaberman about his company's fully enrolled Phase 3 VISTA clinical trial for laru-zova, a gene therapy for X-linked retinitis pigmentosa (RPGRÂ mutations) that's showed promising results in earlier trials. They also discuss Beacon's forthcoming clinical trial for its dry age-related macular degeneration gene therapy.